Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Verena Paul"'
Autor:
Jana Winzig, Laura Inhestern, Désirée Sigmund, Verena Paul, Lesley‐Ann Hail, Stefan Rutkowski, Gabriele Escherich, Corinna Bergelt
Publikováno v:
Cancer Medicine, Vol 13, Iss 10, Pp n/a-n/a (2024)
Abstract Purpose In Germany, children diagnosed with cancer survive their initial disease in more than 80%, and the majority will become long‐term survivors. Around the age of 18, survivors are transferred to adult healthcare. The transition can be
Externí odkaz:
https://doaj.org/article/fd38c7e7e773429fa30818454628a0a8
Autor:
Laura Inhestern, Corinna Bergelt, Gabriele Escherich, Stefan Rutkowski, Verena Paul, Jana Winzig
Publikováno v:
BMJ Open, Vol 12, Iss 4 (2022)
Introduction Patients and families affected by paediatric cancer experience psychosocial burden not only during active treatment but also during follow-up care. Use of health services during follow-up treatment should be organised according to patien
Externí odkaz:
https://doaj.org/article/853ed8606ce7458f93a2222110ecb743
Autor:
Jana Winzig, Laura Inhestern, Verena Paul, Mona L. Nasse, Konstantin A. Krauth, Daniela Kandels, Stefan Rutkowski, Gabriele Escherich, Corinna Bergelt
Publikováno v:
Quality of Life Research.
Purpose Despite advances in cancer treatment, there is a prevalence of pediatric childhood cancer survivors still at risk of developing adverse disease and treatment outcomes, even after the end of treatment. The present study aimed to (1) explore ho
Autor:
Saskia Seiser, Lukas Janker, Nina Zila, Michael Mildner, Ana Rakita, Johannes Matiasek, Andrea Bileck, Christopher Gerner, Verena Paulitschke, Adelheid Elbe-Bürger
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Octenidine dihydrochloride (OCT) is a widely used antiseptic molecule, promoting skin wound healing accompanied with improved scar quality after surgical procedures. However, the mechanisms by which OCT is contributing to tissue regeneration
Externí odkaz:
https://doaj.org/article/ca6e0d3da544492aad3a726a3e29cf09
Autor:
Nina Zila, Andrea Bileck, Besnik Muqaku, Lukas Janker, Ossia M. Eichhoff, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Christopher Gerner, Verena Paulitschke
Publikováno v:
Clinical Proteomics, Vol 15, Iss 1, Pp 1-22 (2018)
Abstract Background MAP kinase inhibitor (MAPKi) therapy for BRAF mutated melanoma is characterized by high response rates but development of drug resistance within a median progression-free survival (PFS) of 9–12 months. Understanding mechanisms o
Externí odkaz:
https://doaj.org/article/3c05226649704612ad3c346883feffbc
Autor:
Bernhard Knapp, Rémi Bardenet, Miguel O Bernabeu, Rafel Bordas, Maria Bruna, Ben Calderhead, Jonathan Cooper, Alexander G Fletcher, Derek Groen, Bram Kuijper, Joanna Lewis, Greg McInerny, Timo Minssen, James Osborne, Verena Paulitschke, Joe Pitt-Francis, Jelena Todoric, Christian A Yates, David Gavaghan, Charlotte M Deane
Publikováno v:
PLoS Computational Biology, Vol 11, Iss 4, p e1004214 (2015)
Externí odkaz:
https://doaj.org/article/ca32359ebf3146958b35ab96110b6382
Autor:
Verena Paulitschke, Silke Gruber, Elisabeth Hofstätter, Verena Haudek-Prinz, Philipp Klepeisz, Nikolaus Schicher, Constanze Jonak, Peter Petzelbauer, Hubert Pehamberger, Christopher Gerner, Rainer Kunstfeld
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e46103 (2012)
Peroxisome proliferator-activated receptors (PPARs) have been originally thought to be restricted to lipid metabolism or glucose homeostasis. Recently, evidence is growing that PPARγ ligands have inhibitory effects on tumor growth. To shed light on
Externí odkaz:
https://doaj.org/article/7970010bdbb84538af163b7aa2e40f33
Autor:
Verena Paul-Zinserling
Publikováno v:
Forschungen und Berichte. 27:263